Crosstalk between hesperetin and miR-486-5p in triple-negative breast cancer (TNBC): An approach towards precision medicine von Abdallah, R.M., Youness, R.A., El Meckawy, N., El Sebaaei, A., Abdelmotaal, A.A., Assal, R.A.

Volltext

Paradoxical effects of miR-486-5p on the oncogenic and immunogenic profiles in triple negative breast cancer (TNBC) von Abdallah, R., Youness, R.A., El Meckawy, N., El Sebaei, A.F., Abdelmotaal, A., Assal, R.A.

Volltext

422 (PB-055) - Paradoxical effects of miR-486-5p on the oncogenic and immunogenic profiles in triple negative breast cancer (TNBC) von Abdallah, R., Youness, R.A., El Meckawy, N., El Sebaei, A.F., Abdelmotaal, A., Assal, R.A.

Volltext

88PCrosstalk between hesperetin and miR-486-5p in triple-negative breast cancer (TNBC): An approach towards precision medicine von Abdallah, R M, Youness, R A, El Meckawy, N, El Sebaaei, A, Abdelmotaal, A A, Assal, R A

Volltext

Down-regulated miR-486-5p acts as a tumor suppressor in breast cancer patients by targeting the metastatic mediator ICAM-1 von Abdallah, R., Youness, R.A., El Meckawy, N., El Sebaei, A.F., Abdelmotaal, A., Assal, R.A.

Volltext